Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Activity of ketoconazole after taxane-based chemotherapy in castration-resistant prostate cancer.

Activity of ketoconazole after taxane-based chemotherapy in castration-resistant prostate cancer. BJU Int. 2010 May; 105(10):1392-6.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.